4/16
Perelman School of Medicine
Out-of-pocket cost increase could put HIV prevention medications out of reach
A Penn Medicine study finds that even modest increases in out-of-pocket costs for HIV prevention drugs could double the rate at which prescriptions go unfilled.
New AI tool brings precision pathology for cancer into quicker, sharper focus
Researchers at Penn Medicine have developed an artificial intelligence tool to quickly analyze gene activities in medical images and provide single-cell insight into diseases in tissues and tissue microenvironments.
How Penn Medicine is changing the world with mRNA
Vaccines are just the beginning of the potential for messenger RNA, the Nobel Prize-winning technology.
New treatment reverses Alzheimer’s disease signs
According to a preclinical study from Penn Medicine researchers, a molecular compound mimics the effect of natural chaperones that are depleted in the aging brain.
Penn Medicine sets a worldwide record with 100 kidney paired donation transplants in a year
The Penn Transplant Institute coordinates with the National Kidney Register to help pair the more than 90,000 patients on the waitlist with a deceased donor.
Research shows how stress activates neurons that disrupt sleep
New research from Penn Medicine shows suppressing these neurons may be a promising target for therapies to treat stress-related sleep disorders, like insomnia and PTSD.
First in-human clinical trial of CAR T cell therapy with new binding mechanism shows promising early responses
The therapy tested in a Phase 1 clinical trial might drastically change the way the T cells work, potentially allowing the new CAR T cell product to work where other products have failed.
One in six patients with opioid use disorder leaving the hospital before completing treatment
A new Penn Medicine analysis shows that discharges too early for patients with opioid use disorder increased over 50% between 2016 and 2020.
Could a single shot heal heart disease?
Experts at Penn Medicine are researching novel treatments for heart disease, including CRISPR gene editing technology, CAR T technology, and mRNA injections.
Lidocaine may be able to kill certain cancer cells by activating bitter taste receptors
A preclinical Penn Medicine study explains the previously observed anti-cancer effect of the common anesthetic drug.
In the News
How to die in good health
PIK Professor Ezekiel Emanuel says that incessantly preparing for old age mistakes a long life for a worthwhile one.
FULL STORY →
Mayor Parker’s plan to ‘remove the presence of drug users’ from Kensington raises new questions
Shoshana Aronowitz of the School of Nursing and Ashish Thakrar of the Perelman School of Medicine comment on the lack of specificity in Philadelphia’s plan to remove drug users from Kensington and on the current state of drug treatment in the city.
FULL STORY →
How many patients would recommend their Philly-area hospital to family and friends? Check your local hospital
The Hospital of the University of Pennsylvania has been named one of the most recommended acute-care facilities by patients in the Philadelphia area.
FULL STORY →
Homeward bound: When a Penn Medicine nurse was diagnosed with uterine cancer, she turned to the service dogs she helped to train
A profile highlights Maria Wright of Penn Medicine Lancaster General Health, from her volunteer work connecting people with service dogs to her cancer diagnosis and her own journey applying for a service dog.
FULL STORY →
UPenn medical school names first vice dean of AI
Mary Ritchie has been named the vice dean of artificial intelligence and computing at the Perelman School of Medicine. Mitchell Schnall has been named the first senior vice president for data and technology solutions at the University of Pennsylvania Health System.
FULL STORY →